Freeze-dried whole plasma: Evaluating sucrose, trehalose, sorbitol, mannitol and glycine as stabilizers
Authors:
- Irina BakaltchevaIBIrina Bakaltcheva
- Anne Marie O'SullivanAOAnne Marie O'Sullivan
- Peter HmelPHPeter Hmel
- Helen OgbuHOHelen Ogbu
- 1 January 2007
- journal article
- clinical trial
- Published by Elsevier in Thrombosis Research
- Vol. 120 (1) , 105-116
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Survival analysis of patients with haemophilia at the International Haemophilia Training Centre, Bangkok, ThailandHaemophilia, 2004
- Modified formulation of CPDA for storage of whole blood, and of SAGM for storage of red blood cells, to maintain the concentration of 2,3‐diphosphoglycerateVox Sanguinis, 2003
- Fundamentals of the psoralen-based Helinx™ technology for inactivation of infectious pathogens and leukocytes in platelets and plasmaSeminars in Hematology, 2001
- B-domain deleted recombinant factor VIII formulation and stabilitySeminars in Hematology, 2001
- The viability of autologous human red cells stored in additive solution 5 and exposed to 25°C for 24 hoursTransfusion, 1999
- Development of a Freeze-Dried Albumin-Free Formulation of Recombinant Factor VIII SQPharmaceutical Research, 1997
- The effect of hypotonicity, glutamine, and glycine on red cell preservationTransfusion, 1997
- Manufacture and in vitro Characterization of a Solvent/Detergent‐Treated Human PlasmaVox Sanguinis, 1992
- Solvent/detergent-treated plasma: a virus-inactivated substitute for fresh frozen plasmaBlood, 1992
- Statement on Normal (Whole, Pooled) Human PlasmaTransfusion, 1968